Labcorp raises annual profit forecast on strong testing demand

July 30 (Reuters) - Laboratory operator Labcorp raised its annual profit forecast and posted better-than-expected second-quarter results on Thursday, as steady demand for diagnostic testing and growth in its drug-development services business boosted performance. Shares of the company fell about 6% in premarket trading.
Reported by 1 outlet — Investing.com · Stock Market. See all sources ↓
Labcorp raised its annual profit forecast. It reported better-than-expected second‑quarter results. Steady demand for diagnostic testing and growth in drug‑development services helped the performance. Shares fell about 6% in premarket trading.
Why it matters
The update shows how the health‑testing sector is doing, which can affect investors and patients who rely on Labcorp’s services.
- What did Labcorp do with its profit forecast?
- Labcorp raised its annual profit forecast.
- Why did Labcorp’s results improve?
- Steady demand for diagnostic testing and growth in its drug‑development services boosted performance.
- What happened to Labcorp’s shares after the announcement?
- Shares fell about 6% in premarket trading.
How outlets are framing the same story
Here's how each outlet is covering the story — compare their headlines and timing at a glance.
All outlets present the same facts with similar emphasis; there is no noticeable difference in framing.
- Coverage card1 outlet1CoverageScouting report
Labcorp raises annual profit forecast on strong testing demand
Sources1TypeCoverageInvesting.com · Stock Market